Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

The trial met both primary endpoints, with tirzepatide showing a 38% decrease in heart failure outcomes compared to placebo.

Third cohort dose is one million CAR positive cells; ten times higher than the first cohort dose . SAN JOSE, Calif., Nov. 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" ...

Presented data at EADV supporting potential of ESK-001 as differentiated oral treatment in immune-mediated diseases through maximal TYK2 inhibition - - Continued to advance three clinical programs ...

On September 16, 2024, Immatics announced the proof-of-concept clinical data for the first candidate of its next-generation, ...

Researchers sought to determine the relationship between sleep duration and clinical depression in patients with cardiovascular disease.

Plozasiran specifically targets and reduce the production of APOC3, thereby reducing triglyceride levels and lowering the ...

Researchers have discovered that the Covid-19 virus may hold unexpected benefits for cancer treatment. The virus triggers the ...

A simplified imaging protocol using just five views still had good accuracy with a median AUROC of 0.85 and normalized mean ...

Nanoform Finland Plc. November 18, 2024. 08:10 a.m. Finnish time / 07:10 a.m. Swedish time. Nanoform Q3 2024 report: Record number of new projects signed. A ...

Schrödinger has already generated several computational predictive models of off-target drug activity. The company’s recent advances characterizing the structure of safety-related proteins such as ...

Delcath Systems sees strong growth in Q3 earnings, driven by HEPZATO and CHEMOSAT sales. Read my DCTH Q3 earnings analysis.